XTNT Fundamental Analysis - XTANT MEDICAL HOLDINGS INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to XTNT. XTNT was compared to 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of XTNT have multiple concerns. While showing a medium growth rate, XTNT is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year XTNT has reported negative net income.

XTNT had a positive operating cash flow in the past year.

XTNT had negative earnings in 4 of the past 5 years.

XTNT had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

XTNT has a better Return On Assets (-4.43%) than 66.32% of its industry peers.

XTNT has a Return On Equity of -9.44%. This is in the better half of the industry: XTNT outperforms 66.32% of its industry peers.

XTNT has a better Return On Invested Capital (0.03%) than 65.26% of its industry peers.

		Industry Rank	Sector Rank
ROA	-4.43%
ROE	-9.44%
ROIC	0.03%

ROA(3y)-10.3%

ROA(5y)-11.34%

ROE(3y)-20.61%

ROE(5y)-25.18%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of XTNT (0.02%) is better than 65.26% of its industry peers.

XTNT has a better Gross Margin (60.16%) than 60.53% of its industry peers.

XTNT's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	0.02%
PM (TTM)	N/A
GM	60.16%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.35%

GM growth 5Y-2.41%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XTNT is destroying value.

Compared to 1 year ago, XTNT has more shares outstanding

Compared to 5 years ago, XTNT has more shares outstanding

Compared to 1 year ago, XTNT has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.53, we must say that XTNT is in the distress zone and has some risk of bankruptcy.

XTNT has a Altman-Z score of -0.53. This is comparable to the rest of the industry: XTNT outperforms 41.05% of its industry peers.

A Debt/Equity ratio of 0.46 indicates that XTNT is not too dependend on debt financing.

XTNT has a Debt to Equity ratio (0.46) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.46
Debt/FCF	N/A
Altman-Z	-0.53

ROIC/WACC0

WACC8.94%

2.3 Liquidity

A Current Ratio of 2.47 indicates that XTNT has no problem at all paying its short term obligations.

With a Current ratio value of 2.47, XTNT perfoms like the industry average, outperforming 50.00% of the companies in the same industry.

XTNT has a Quick Ratio of 1.16. This is a normal value and indicates that XTNT is financially healthy and should not expect problems in meeting its short term obligations.

With a Quick ratio value of 1.16, XTNT is not doing good in the industry: 70.00% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	2.47
Quick Ratio	1.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for XTNT have decreased strongly by -100.00% in the last year.

Looking at the last year, XTNT shows a quite strong growth in Revenue. The Revenue has grown by 15.16% in the last year.

Measured over the past years, XTNT shows a quite strong growth in Revenue. The Revenue has been growing by 12.64% on average per year.

EPS 1Y (TTM)-100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%166.67%

Revenue 1Y (TTM)15.16%

Revenue growth 3Y28.5%

Revenue growth 5Y12.64%

Sales Q2Q%18.26%

3.2 Future

Based on estimates for the next years, XTNT will show a very strong growth in Earnings Per Share. The EPS will grow by 30.30% on average per year.

Based on estimates for the next years, XTNT will show a small growth in Revenue. The Revenue will grow by 3.31% on average per year.

EPS Next Y108.5%

EPS Next 2Y42.92%

EPS Next 3Y30.31%

EPS Next 5YN/A

Revenue Next Year10.6%

Revenue Next 2Y0.34%

Revenue Next 3Y3.31%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

XTNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

A Price/Forward Earnings ratio of 151.12 indicates a quite expensive valuation of XTNT.

66.32% of the companies in the same industry are more expensive than XTNT, based on the Price/Forward Earnings ratio.

XTNT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.33.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	151.12

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XTNT indicates a somewhat cheap valuation: XTNT is cheaper than 71.58% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	30.13

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

XTNT's earnings are expected to grow with 30.30% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y42.92%

EPS Next 3Y30.31%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

XTNT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

XTANT MEDICAL HOLDINGS INC

NYSEARCA:XTNT (10/23/2025, 8:04:00 PM)

After market: 0.78 +0.01 (+1.21%)

0.7707

-0.01 (-1.45%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)08-12 2025-08-12/bmo

Earnings (Next)10-30 2025-10-30/bmo

Inst Owners57.12%

Inst Owner Change0%

Ins Owners14.93%

Ins Owner Change-0.26%

Market Cap107.90M

Revenue(TTM)127.77M

Net Income(TTM)-4581000

Analysts85

Price Target1.79 (132.26%)

Short Float %0.06%

Short Ratio0.84

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)198.04%

Min EPS beat(2)100%

Max EPS beat(2)296.08%

EPS beat(4)2

Avg EPS beat(4)77.12%

Min EPS beat(4)-56.86%

Max EPS beat(4)296.08%

EPS beat(8)3

Avg EPS beat(8)73.86%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)7.07%

Min Revenue beat(2)3.39%

Max Revenue beat(2)10.74%

Revenue beat(4)2

Avg Revenue beat(4)1.19%

Min Revenue beat(4)-6.52%

Max Revenue beat(4)10.74%

Revenue beat(8)6

Avg Revenue beat(8)5.84%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)150%

EPS NY rev (3m)128.57%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)4.81%

Revenue NY rev (1m)0%

Revenue NY rev (3m)1.25%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	151.12
P/S	0.84
P/FCF	N/A
P/OCF	71.88
P/B	2.22
P/tB	3.2
EV/EBITDA	30.13

EPS(TTM)-0.04

EYN/A

EPS(NY)0.01

Fwd EY0.66%

FCF(TTM)-0.02

FCFYN/A

OCF(TTM)0.01

OCFY1.39%

SpS0.91

BVpS0.35

TBVpS0.24

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.43%
ROE	-9.44%
ROCE	0.04%
ROIC	0.03%
ROICexc	0.03%
ROICexgc	0.04%
OM	0.02%
PM (TTM)	N/A
GM	60.16%
FCFM	N/A

ROA(3y)-10.3%

ROA(5y)-11.34%

ROE(3y)-20.61%

ROE(5y)-25.18%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.35%

GM growth 5Y-2.41%

F-Score5

Asset Turnover1.23

Health

		Industry Rank	Sector Rank
Debt/Equity	0.46
Debt/FCF	N/A
Debt/EBITDA	4.97
Cap/Depr	97.07%
Cap/Sales	3.39%
Interest Coverage	0.01
Cash Conversion	33.42%
Profit Quality	N/A
Current Ratio	2.47
Quick Ratio	1.16
Altman-Z	-0.53

F-Score5

WACC8.94%

ROIC/WACC0

Cap/Depr(3y)93.26%

Cap/Depr(5y)102.58%

Cap/Sales(3y)2.72%

Cap/Sales(5y)2.97%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%166.67%

EPS Next Y108.5%

EPS Next 2Y42.92%

EPS Next 3Y30.31%

EPS Next 5YN/A

Revenue 1Y (TTM)15.16%

Revenue growth 3Y28.5%

Revenue growth 5Y12.64%

Sales Q2Q%18.26%

Revenue Next Year10.6%

Revenue Next 2Y0.34%

Revenue Next 3Y3.31%

Revenue Next 5YN/A

EBIT growth 1Y100.21%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year230.8%

EBIT Next 3Y49%

EBIT Next 5YN/A

FCF growth 1Y74.12%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y116.46%

OCF growth 3YN/A

OCF growth 5YN/A

XTANT MEDICAL HOLDINGS INC (XTNT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens